X
Mnesys - Team - Maria Luisa Barbaccia

 

Maria Luisa Barbaccia

Maria Luisa Barbaccia

barbaccia@med.uniroma2.it

06-72596314 
Roma (Lazio) Italy
 

Full Professor of Pharmacology

Università degli Studi di Roma - Tor Vergata

Training, research and teaching experience
2024: Honorary Professor - University of Rome Tor Vergata - Department of Systems Medicine
2005-2024: Full Professor of Pharmacology - University of Rome Tor Vergata - Department of Systems Medicine
2002-2005: Extraordinary Professor of Pharmacology, University of Rome Tor Vergata
1991-2002: Associate Professor of Pharmacology
1988-1991: Associate Professor of Chemotherapy
1985-1998: “Res. Ass. Professor”, Georgetown University Medical School, Dept. Pharmacology, Washington DC, USA
1984-1985: “Guest Researcher”, Laboratory of Preclinical Pharmacology, NIMH, St. Elizabeth's Hospital, Washington DC, USA
1980-1984: “Fogarty Fellow", Lab Preclin Pharmacol, NIMH, St. Elizabeth's Hospital, Washington DC, USA;
1979: Magna cum laude Degree in Medicine and Surgery, University of Milan

Maria Luisa Barbaccia's research focused on the mechanisms by which drugs and psychotropic substances interact with various neurotransmitter systems (particularly monoaminergics and GABAergics) in the central nervous system. He also studied neurosteroids, steroids produced from scratch or through the metabolism of circulating steroids by the central nervous system. These steroids can influence, through multiple molecular mechanisms, some important brain functions, their modulation by drugs, substances of abuse, and stress, as well as the possible role of neurosterodes in the process of neuronal differentiation.

Bibliometric indices
Total number of publications: 90
H-index: 39
Number of citations: 6177



Last degree achieved

Graduating class: Laurea in Medicina
University: Milano - Università degli Studi di Milano Statale
Year: 1979


Language skills

Italian native speaker: Yes


Job

Currently Employed
Up to 3 years

Pubblications

Project Lines

Validation of VEGFR-1 targeting in patient derived glioblastoma experimental models

-

Validation of VEGFR-1 targeting in patient derived glioblastoma experimental models

Read All